Aviso: Este sitio agrega datos públicos oficiales de la FDA, ClinicalTrials.gov, PubMed y SEC EDGAR solo como referencia general. No constituye asesoramiento médico, diagnóstico, recomendaciones de tratamiento ni asesoramiento de inversión.

PMA de la FDA

Hybrid stent graft, thoracic aortic lesion treatment

Número de PMA: P210006 · 2026-09-08

SolicitanteVascutek, Ltd.
Fecha de decisión2026-09-08
Número PMAP210006
Código de productoQSK
Clase del dispositivoClase 3
Especialidad médicaU
Comité asesorCV

Resumen del dispositivo

Hybrid stent graft, thoracic aortic lesion treatment is the device name listed in this FDA 510(k) record. The listed applicant is Vascutek, Ltd.. It received FDA 510(k) clearance on 2026-09-08. The device is classified under product code QSK. It was reviewed by the CV advisory panel.

Preguntas frecuentes

What is the Hybrid stent graft, thoracic aortic lesion treatment?

Hybrid stent graft, thoracic aortic lesion treatment is a medical device that received FDA 510(k) clearance on 2026-09-08. The listed applicant is Vascutek, Ltd..

When did Hybrid stent graft, thoracic aortic lesion treatment receive FDA 510(k) clearance?

The clearance date for Hybrid stent graft, thoracic aortic lesion treatment can be found in the official FDA records.

Who is the listed applicant for Hybrid stent graft, thoracic aortic lesion treatment?

The FDA 510(k) record lists Vascutek, Ltd. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Hybrid stent graft, thoracic aortic lesion treatment?

The FDA product code for Hybrid stent graft, thoracic aortic lesion treatment is QSK.

Ensayos clínicos relacionados

Los registros relacionados se emparejan automáticamente mediante nombres, códigos de producto u otros metadatos. Un emparejamiento no establece una relación clínica, científica, corporativa o regulatoria verificada; revise las fuentes oficiales enlazadas.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Fuente oficial

Ver en la base de datos de la FDA →

Datos procedentes de la API abierta de la FDA. Para obtener la información más actualizada y autoritativa, consulte siempre el registro oficial.

↑